About Dr Chris Hayward

  • I have a broad range of interests and areas of expertise;
  • Inflammatory Bowel Disease; management, treatment and surveillance of Ulcerative Colitis & Crohn’s disease. I have over 15 years experience managing individuals with  IBD as part of a clinical team, including the use of all treatment modalities including biologics (Infliximab/Humira). I am local NACC medical representative.
  • Endoscopy; including upper gastrointestinal endoscopy and colonoscopy. I have performed in excess of 5000 colonoscopies with a caecal intubation rate of over 95% and adenoma detection rate of 42 %; I am an accredited bowel cancer-screening colonoscopist. 
I have a major interest in, and wide experience of therapeutic endoscopic procedures including polypectomy and endoscopic mucosal resection.
  • Symptom management and treatment of gastrointestinal infections including post-infective irritable bowel syndrome.
  • The investigation and management of chronic diarrhoea.
  • Gastro-oesophageal reflux.
  • Diagnosis and management of Irritable bowel syndrome and the effect of diet on digestive symptoms.
  • Investigation of iron deficiency anaemia, overt and occult gastrointestinal bleeding.
  • Early diagnosis and management of early GI cancer including colorectal cancer screening: I am involved in the Bowel Cancer Screening programme for the South Devon Bowel Screening Centre.
  • I have recently returned from visiting Japanese centres of excellence to see how they manage early GI cancer with endoscopic treatment including endoscopic submucosal dissection (ESD). ESD enables an en bloc resection (single fragment) of large benign and early (t1) cancer, This reduces the risk of local recurrence following endoscopic resection when compared to the alternative technique (peicemeal Endoscopic mucosal resection) . ESD also allows a more accurate histological assessment of the lesion which is important if the lesion has focus of malignancy.
Designed by Neovirtua